Printer Friendly
The Free Library
14,537,013 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Merit Medical Reports Record Net Income and Sales for the Year Ended December 31, 2002 and Gives Guidance for 2003.


Business Editors & Health/Medical Writers

SOUTH JORDAN, Utah--(BUSINESS WIRE)--Feb. 19, 2003

Merit Medical Systems, Inc. (Nasdaq:MMSI MMSI Maritime Mobile Service Identity
MMSI Miniature Munitions/Store Interface
MMSI Military Membership Status Identifier
) a manufacturer and marketer of proprietary disposable products Disposable products are items that are not intended by the manufacturer to be reused more than once or a few times as compared to more permanent serviceable and reusable items. Some products that have disposable versions are:
  • diapers
  • cigarette lighters
  • flatware
 used in cardiology cardiology

Medical specialty dealing with heart diseases and disorders. It began with the 1749 publication by Jean Baptiste de Sénac of contemporary knowledge of the heart. Diagnostic methods improved in the 19th century, and in 1905 the electrocardiograph was invented.
 and radiology radiology, branch of medicine specializing in the use of X rays, gamma rays, radioactive isotopes, and other forms of radiation in the diagnosis and treatment of disease.  procedures, reported record net income of $11.3 million, or $0.77 per share, for the year ended December 31, 2002, compared with $6.7 million, or $0.50 per share in 2001, a gain of 69 percent.

Revenues for 2002 were a record $116.2 million compared with $104 million for the same period in 2001, a gain of 12 percent.

Net income for the fourth quarter ended December 31, 2002, was $3.2 million, or $0.21 per share, compared with $1.9 million, or $0.13 per share, in the 2001 fourth quarter, a gain of 62 percent. Revenues for the 2002 fourth quarter were $29.4 million compared with $25.3 million in the fourth quarter of 2000, a gain of 16 percent.

Every group of the Company's products witnessed growth in 2002 compared to 2001. Both the custom kits and stand-alone products groups rose by 13 percent; followed by inflation devices, which grew by 11 percent; and catheters, which increased 6 percent.

For the fourth quarter of 2002, sales of the Company's inflation devices grew by 20 percent; stand-alone products sales rose 19 percent, custom kits sales grew by 18 percent; and catheter catheter /cath·e·ter/ (kath´e-ter)
1. a tubular, flexible surgical instrument that is inserted into a cavity of the body to withdraw or introduce fluid.

2. urethral c.
 sales declined by 3 percent compared to the fourth quarter of 2001.

Fred P. Lampropoulos, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Merit, said, "We continued our improved performance last year in terms of employee productivity gains, inventory reduction, new product introductions, gross margin improvements and cash flow.

"We were able to reduce our inventory by approximately $2.1 million last year, while growing our revenues by 12 percent. Inventory turns rose from 2.9 times in 2001 to 3.4 times in 2002. All of these positive gains have contributed to a rising cash position. Our cash balance rose to almost $10 million at year-end since we retired our debt in March 2002. Additionally, the Company opted to purchase its Irish facility for $2.6 million in cash.

"In 2003, we will continue to see productivity gains, benefits from cost-savings programs, and benefits from new product introductions. Costs will rise this year in a number of areas, including $400,000 in health care premiums which the Company is absorbing rather than passing on to our employees, a 23 percent rise in property and casualty insurance premiums due to the combination of the increased value of our business and rate increases, and a much higher income tax rate for 2003," Mr. Lampropoulos continued.

The Company's gross margin improved to 41.7 percent in 2002 compared with 36.6 percent in 2001. This rise was due largely to employee productivity improvements. In addition, the implementation during 2001 and 2002 of cost-saving programs throughout the organization contributed importantly to the margin gains. Gross margin for the fourth quarter ended December 31, 2002, was 43.4 percent compared with 38.5 percent in the fourth quarter of 2001.

Total operating expenses Operating expenses

The amount paid for asset maintenance or the cost of doing business, excluding depreciation. Earnings are distributed after operating expenses are deducted.
 for 2002 grew slightly as a percent of sales to 27.3 percent compared with 27.1 percent in 2001. Selling, general and administrative expenses rose 15.4 percent, largely due to increases in commissions paid commensurate com·men·su·rate  
adj.
1. Of the same size, extent, or duration as another.

2. Corresponding in size or degree; proportionate: a salary commensurate with my performance.

3.
 with sales growth, as well as the addition of personnel in the sales and marketing organizations. Research and development expenditures in dollars were essentially flat in 2002 compared with 2001.

Income before income tax expense rose by 71 percent to $16.8 million in 2002 compared with $9.8 million in 2001. Due to this increase, the Company's income-tax rate rose to 32.5 percent in 2002 compared to 31.2 percent in 2001. It is expected that the Company's income-tax rate will rise more rapidly in 2003 to approximately 35.5 percent.

Merit also said it expects revenues and earnings per share for the year ended December 31, 2003, to be in the range of $126.9 million-$129.0 million, and $0.87-$0.93, respectively.


                           INCOME STATEMENT
                           ----------------

                           3 Mos. Ended 12/31     12 Mos. Ended 12/31
                           ------------------     -------------------
                            2002        2001        2002        2001
                           ------      ------     -------     -------
                                (In Thousands Except Share Data)

REVENUES                  $29,425     $25,289    $116,227    $104,036

COST OF SALES              16,651      15,562      67,712      65,938

GROSS PROFIT               12,774       9,727      48,515      38,098

OPERATING EXPENSES:
Selling, General and
 Administration             7,078       5,825      27,732      24,041
Research and
 Development                1,132         953       4,008       4,118
TOTAL OPERATING
 EXPENSES                   8,210       6,778      31,740      28,159

OPERATING INCOME            4,564       2,949      16,775       9,939

OTHER EXPENSE -
 (INCOME)                     (63)         52          13         151

PRETAX INCOME               4,627       2,897      16,762       9,788

INCOME TAX EXPENSE          1,471         951       5,452       3,052

NET INCOME                  3,156       1,946      11,310       6,736

EARNINGS PER COMMON
 SHARE-
Basic:                      $0.23       $0.15       $0.83       $0.53
Diluted:                    $0.21       $0.13       $0.77       $0.50

AVERAGE COMMON SHARES-
Basic:                 13,827,780  13,315,085  13,627,178  12,677,611
Diluted:               14,954,141  14,436,486  14,759,128  13,429,585



                            BALANCE SHEET
                            -------------

                                            12/31/02         12/31/01
                                           ----------       ----------
                                                 (In $ Thousands)
ASSETS

CASH                                          $9,684             $342
TRADE RECEIVABLES (NET)                       15,247           14,748
INVENTORIES                                   18,699           20,824
OTHER CURRENT ASSETS                           4,166            1,688
                                           ----------       ----------
TOTAL CURRENT ASSETS                          47,796           37,602
PROPERTY & EQUIPMENT (NET)                    25,412           21,823
OTHER ASSETS                                   6,726            7,234
                                           ----------       ----------
TOTAL ASSETS                                 $79,934          $66,659
                                           ==========       ==========

LIABILITIES AND STOCKHOLDERS' EQUITY

TOTAL CURRENT LIABILITIES                    $11,586          $10,690
OTHER LIABILITIES                              4,933            2,583
LONG-TERM DEBT                                    16            5,727
STOCKHOLDERS' EQUITY                          63,399           47,659
                                           ----------       ----------
TOTAL LIABILITIES AND
    STOCKHOLDERS' EQUITY                     $79,934          $66,659
                                           ==========       ==========



CONFERENCE CALL

Merit Medical Systems, Inc. invites all interested parties to join its officers in their quarterly earnings conference call and 2003 guidance to be held today, February 19, 2003, at 4:15 PM Eastern Time (3:15 PM Central, 2:15 PM Mountain, and 1:15 PM Pacific). During the conference call, the results of operations for the year and quarter ended December 31, 2002 will be discussed in more detail, together with the Company's expectations for 2003 and trends that may affect its future results. The telephone numbers are: Domestic: 800/218-0713, and International: 303/262-2190. A rebroadcast is available through August 20, 2003, on the Internet Internet

Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the
 by accessing the CCBN CCBN Central Coast Bancorp
CCBN Charles County Business Network
 logo under "Webcasts" at www.merit.com. The rebroadcast is also available through August 20, 2003 at www.ccbn.com.

ABOUT MERIT

Founded in 1987, Merit Medical Systems, Inc. is a publicly traded company publicly traded company

A company whose shares of common stock are held by the public and are available for purchase by investors. The shares of publicly traded firms are bought and sold on the organized exchanges or in the over-the-counter market.
 engaged in the development, manufacture and distribution of proprietary disposable disposable Nursing adjective Referring to that which is discarded or disposed of noun An item used in health care-related Pt contact which is discarded after use–eg masks, gloves, gowns, needles, paper products, syringes, wipes. See Biohazardous waste.  medical products used in interventional and diagnostic procedures, particularly in cardiology and radiology. The Company serves client hospitals worldwide with a domestic and international sales force totaling approximately 70 individuals. Merit employs approximately 1,070 individuals worldwide, with manufacturing facilities in South Jordan and Salt Lake City, Utah For ships of the United States Navy of the same name, see .
Salt Lake City is the capital and the most populous city of the U.S. state of Utah. The name of the city is often shortened to Salt Lake, or its initials, S.L.C.
; Santa Clara, California Santa Clara, California (IPA: /ˌsæntəˈklærə/) , founded in 1777 and incorporated in 1852, is a city in Santa Clara County, in the U.S. state of California. ; Angleton, Texas
This article is about the city in Texas. For the CIA official, please see James Jesus Angleton.


Angleton is the county seatGR6 of Brazoria County in the U.S.
; and Galway, Ireland. For more information about Merit, visit www.merit.com.

Statements contained in this release which are not purely historical are forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995 and are subject to risks and uncertainties such as those described in the Company's Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the year ended December 31, 2001. Such risks and uncertainties include introduction of products in a timely fashion, market acceptance of new products, cost increases, fluctuations in and obsolescence ob·so·les·cent  
adj.
1. Being in the process of passing out of use or usefulness; becoming obsolete.

2. Biology Gradually disappearing; imperfectly or only slightly developed.
 of inventory, price and product competition, availability of labor and materials labor and materials (time and materials) n. what some builders or repair people contract to provide and be paid for, rather than a fixed price or a percentage of the costs. , development of new third-party products and techniques that render the Company's products obsolete OBSOLETE. This term is applied to those laws which have lost their efficacy, without being repealed,
     2. A positive statute, unrepealed, can never be repealed by non-user alone. 4 Yeates, Rep. 181; Id. 215; 1 Browne's Rep. Appx. 28; 13 Serg. & Rawle, 447.
, delays in obtaining regulatory approvals, potential product recalls, foreign currency fluctuations, changes in health care markets related to health care reform initiatives, litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
 and other factors referred to in the Company's 10-K and other reports filed with the Securities and Exchange Commission. All subsequent forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety The whole, in contradistinction to a moiety or part only. When land is conveyed to Husband and Wife, they do not take by moieties, but both are seised of the entirety.  by these cautionary statements. Actual results may differ materially from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 19, 2003
Words:1375
Previous Article:Merant Introduces Industry's Most Complete Solutions Package for Enterprise Change Management.
Next Article:Second-Annual International Satellite and Communications Exchange Conference and Expo Scheduled for August 18-21.
Topics:



Related Articles
Merit Medical Systems, Inc. Reports Record Results for Fourth Quarter and Year Ended December 31, 1996.
Merit Medical Systems Changes Guidance for Fourth Quarter 2002.
Medical Action Industries Reports Improved Operating Results and Record Revenues for the Three and Six Months Ended September 30, 2002.
Medical Action Industries Reports Record Earnings and Revenues for the Three and Nine Months Ended December 31, 2002.
Merit Medical Systems Inc. Reports 61 Percent Rise in Net Income Including Extra Items on Record Revenues of $31.7 Million for First Quarter 2003.
Medical Action Industries Reports Record Earnings and Revenues for the Fiscal Year Ended March 31, 2003; Record Fourth Quarter Net Income Rises 39%...
Medical Action Industries Reports Record Earnings and Revenues for the Three and Nine Months Ended December 31, 2003.
Guidant Reports Record Fourth Quarter Sales of $951 Million, 8 Percent Sales Growth; Record Full-Year 2003 Sales of $3.7 Billion, 17 Percent Sales...
Merit Medical Reports Record Net Income and Sales for the Year Ended Dec. 31, 2003.
Merit Medical Reports Record Sales for the Fourth Quarter and Year Ended Dec. 31, 2004.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles